Urinary cytomorphology and clinical correlates of prostatic small cell neuroendocrine carcinoma

Adam D. Toll, Syed Z Ali

Research output: Contribution to journalArticle

Abstract

Background: Small cell carcinoma (SCC) of the prostate represents a rare form of prostatic carcinoma. While the tumor is often considered to arise from neuroendocrine proliferation or possibly dedifferentiation of an acinar carcinoma, the precise etiology remains uncertain. The diagnosis of prostatic SCC in urine has to date not been described. Methods: A retrospective review was performed at a tertiary-care hospital, and 3 patients with prostatic SCC in voided urinary specimens were identified. The following clinical data were collected for each case: age, gender, treatment and follow-up information, when available. Results: The patient age range was 70-86 years, all male. Two patients had known metastatic adenocarcinoma of the prostate, and 1 had recently presented with prostatic SCC. One patient with metastatic disease died shortly after diagnosis, the other was lost to follow-up. The third patient with a recent presentation has yet to have a treatment plan finalized. Conclusions: Our results highlight the importance of making this uncommon diagnosis as it may carry significant treatment and prognostic importance. Future work should hopefully clarify the role of ERG gene rearrangements in the pathogenesis of prostatic SCC, as there is a potential role here for targeted therapy.

Original languageEnglish (US)
Pages (from-to)495-500
Number of pages6
JournalActa Cytologica
Volume57
Issue number5
DOIs
StatePublished - 2013

Fingerprint

Neuroendocrine Carcinoma
Small Cell Carcinoma
Prostate
Acinar Cell Carcinoma
Gene Rearrangement
Lost to Follow-Up
Tertiary Healthcare
Therapeutics
Tertiary Care Centers
Adenocarcinoma
Urine
Carcinoma
Neoplasms

Keywords

  • Prostate
  • Small cell carcinoma
  • Urine diagnosis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology

Cite this

Urinary cytomorphology and clinical correlates of prostatic small cell neuroendocrine carcinoma. / Toll, Adam D.; Ali, Syed Z.

In: Acta Cytologica, Vol. 57, No. 5, 2013, p. 495-500.

Research output: Contribution to journalArticle

@article{914bc35822b64e85aaec9c401b96706e,
title = "Urinary cytomorphology and clinical correlates of prostatic small cell neuroendocrine carcinoma",
abstract = "Background: Small cell carcinoma (SCC) of the prostate represents a rare form of prostatic carcinoma. While the tumor is often considered to arise from neuroendocrine proliferation or possibly dedifferentiation of an acinar carcinoma, the precise etiology remains uncertain. The diagnosis of prostatic SCC in urine has to date not been described. Methods: A retrospective review was performed at a tertiary-care hospital, and 3 patients with prostatic SCC in voided urinary specimens were identified. The following clinical data were collected for each case: age, gender, treatment and follow-up information, when available. Results: The patient age range was 70-86 years, all male. Two patients had known metastatic adenocarcinoma of the prostate, and 1 had recently presented with prostatic SCC. One patient with metastatic disease died shortly after diagnosis, the other was lost to follow-up. The third patient with a recent presentation has yet to have a treatment plan finalized. Conclusions: Our results highlight the importance of making this uncommon diagnosis as it may carry significant treatment and prognostic importance. Future work should hopefully clarify the role of ERG gene rearrangements in the pathogenesis of prostatic SCC, as there is a potential role here for targeted therapy.",
keywords = "Prostate, Small cell carcinoma, Urine diagnosis",
author = "Toll, {Adam D.} and Ali, {Syed Z}",
year = "2013",
doi = "10.1159/000351301",
language = "English (US)",
volume = "57",
pages = "495--500",
journal = "Acta Cytologica",
issn = "0001-5547",
publisher = "Science Printers and Publishers Inc.",
number = "5",

}

TY - JOUR

T1 - Urinary cytomorphology and clinical correlates of prostatic small cell neuroendocrine carcinoma

AU - Toll, Adam D.

AU - Ali, Syed Z

PY - 2013

Y1 - 2013

N2 - Background: Small cell carcinoma (SCC) of the prostate represents a rare form of prostatic carcinoma. While the tumor is often considered to arise from neuroendocrine proliferation or possibly dedifferentiation of an acinar carcinoma, the precise etiology remains uncertain. The diagnosis of prostatic SCC in urine has to date not been described. Methods: A retrospective review was performed at a tertiary-care hospital, and 3 patients with prostatic SCC in voided urinary specimens were identified. The following clinical data were collected for each case: age, gender, treatment and follow-up information, when available. Results: The patient age range was 70-86 years, all male. Two patients had known metastatic adenocarcinoma of the prostate, and 1 had recently presented with prostatic SCC. One patient with metastatic disease died shortly after diagnosis, the other was lost to follow-up. The third patient with a recent presentation has yet to have a treatment plan finalized. Conclusions: Our results highlight the importance of making this uncommon diagnosis as it may carry significant treatment and prognostic importance. Future work should hopefully clarify the role of ERG gene rearrangements in the pathogenesis of prostatic SCC, as there is a potential role here for targeted therapy.

AB - Background: Small cell carcinoma (SCC) of the prostate represents a rare form of prostatic carcinoma. While the tumor is often considered to arise from neuroendocrine proliferation or possibly dedifferentiation of an acinar carcinoma, the precise etiology remains uncertain. The diagnosis of prostatic SCC in urine has to date not been described. Methods: A retrospective review was performed at a tertiary-care hospital, and 3 patients with prostatic SCC in voided urinary specimens were identified. The following clinical data were collected for each case: age, gender, treatment and follow-up information, when available. Results: The patient age range was 70-86 years, all male. Two patients had known metastatic adenocarcinoma of the prostate, and 1 had recently presented with prostatic SCC. One patient with metastatic disease died shortly after diagnosis, the other was lost to follow-up. The third patient with a recent presentation has yet to have a treatment plan finalized. Conclusions: Our results highlight the importance of making this uncommon diagnosis as it may carry significant treatment and prognostic importance. Future work should hopefully clarify the role of ERG gene rearrangements in the pathogenesis of prostatic SCC, as there is a potential role here for targeted therapy.

KW - Prostate

KW - Small cell carcinoma

KW - Urine diagnosis

UR - http://www.scopus.com/inward/record.url?scp=84886381778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886381778&partnerID=8YFLogxK

U2 - 10.1159/000351301

DO - 10.1159/000351301

M3 - Article

C2 - 24021979

AN - SCOPUS:84886381778

VL - 57

SP - 495

EP - 500

JO - Acta Cytologica

JF - Acta Cytologica

SN - 0001-5547

IS - 5

ER -